COMP <GO>

RDZN vs HIT // EV/EBITDA & P/E VALUATION

Roadzen Inc. (NASDAQ) VS. Health In Tech Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: RDZN 2 — HIT 5

■ METRIC PARITY

LAST: $1.12 (-2.61%) • MKT CAP: $95.4M

valuation

—

LAST: $0.61 (-5.89%) • MKT CAP: $39.9M

valuation

—

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RDZN VS. HIT) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	RDZN	HIT	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	—	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	-35.00%	7.50%	-42.50	HIT	/roic <GO>
EV/EBITDA & P/E Valuation ACTIVE	—	—	—	TIE	/valuation <GO>
Free Cash Flow Yield	-21.25%	7.85%	-29.10	HIT	/fcf-yield <GO>
Operating Margin	-25.40%	—	—	TIE	/operating-margins <GO>
Net Profit Margin	-40.90%	3.80%	-44.70	HIT	/net-margins <GO>
Revenue Growth (YoY)	24.20%	71.00%	-46.80	HIT	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	—	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	3/9	7/9	-4.00	HIT	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	48.6	37.3	+11.30	RDZN	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	—	26.2x	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$95.4M	$39.9M	$55.4M	RDZN	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	RDZN REV	HIT REV	RDZN GROSS %	HIT GROSS %	RDZN FCF	HIT FCF
FY 2025	$55.0M	$33.3M	—	—	-$20.3M	$3.1M
FY 2024	$44.3M	$19.5M	—	—	-$18.1M	$2.2M
FY 2023	$46.7M	$19.2M	—	—	-$19.2M	$1.5M

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

RDZN // BETA —

HIT // BETA —